| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
0.265 |
Evidence |
|
| TPSG1 |
TPSG1, PRSS31, TMT: Tryptase gamma precursor |
SERPINA3 |
IPI00550991 |
0.265 |
Evidence |
|
| ZNF24 |
ZNF24, KOX17, ZNF191, ZSCAN3: Zinc finger protein 24 |
ZNF354A |
ZNF354A, EZNF, HKL1, TCF17: Zinc finger protein 354A |
0.265 |
Evidence |
|
| NRL |
NRL: Neural retina-specific leucine zipper protein |
CREBL1 |
IPI00004084 |
0.265 |
Evidence |
|
| DEDD |
DEDD, DEDPRO1, KE05, DEFT: Death effector domain-containing protein |
CARD8 |
CARD8, KIAA0955, NDPP1: Caspase recruitment domain-containing protein 8 |
0.265 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.265 |
Evidence |
|
| GRAP |
GRAP: GRB2-related adapter protein |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
P2RY11 |
P2RY11: P2Y purinoceptor 11 |
0.265 |
Evidence |
|
| ZNF42 |
MZF1, MZF, ZNF42, ZSCAN6: Myeloid zinc finger 1 |
SCAND2 |
SCAND2: SCAN domain-containing protein 2 |
0.265 |
Evidence |
|
| SIRPB1 |
SIRPB1: Signal regulatory protein beta-1 precursor |
HLA-DRB5 |
HLA-DRB3: HLA class II histocompatibility antigen, DRB3-1 beta chain precursor |
0.265 |
Evidence |
|
| KCNV2 |
KCNV2: Potassium voltage-gated channel subfamily V member 2 |
TRPC4 |
TRPC4: Short transient receptor potential channel 4 |
0.265 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
KLK7 |
KLK7, PRSS6, SCCE: Kallikrein-7 precursor |
0.265 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
NCOA2 |
NCOA2, TIF2: Nuclear receptor coactivator 2 |
0.265 |
Evidence |
|
| TLR3 |
TLR3: Toll-like receptor 3 precursor |
IL1RL1 |
IL1RL1, DER4, ST2, T1: Interleukin-1 receptor-like 1 precursor |
0.265 |
Evidence |
|
| TRPC7 |
TRPC7, TRP7: Short transient receptor potential channel 7 |
CNGB3 |
CNGB3: Cyclic nucleotide-gated cation channel beta 3 |
0.265 |
Evidence |
|
| FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
GRB14 |
GRB14: Growth factor receptor-bound protein 14 |
0.265 |
Evidence |
|
| KLK7 |
KLK7, PRSS6, SCCE: Kallikrein-7 precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
0.265 |
Evidence |
|
| SOCS5 |
SOCS5, CIS6, CISH5, CISH6, KIAA0671: Suppressor of cytokine signaling 5 |
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
0.265 |
Evidence |
|
| KLK5 |
KLK5, SCTE, UNQ570/PRO1132: Kallikrein-5 precursor |
SERPINA3 |
IPI00550991 |
0.265 |
Evidence |
|
| GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
OR2B2 |
OR2B2, OR2B9: Olfactory receptor 2B2 |
0.265 |
Evidence |
|
| ADAMTS2 |
ADAMTS2, PCINP, PCPNI: ADAMTS-2 precursor |
TIMP3 |
TIMP3: Metalloproteinase inhibitor 3 precursor |
0.265 |
Evidence |
|
| TNFRSF7 |
CD27, TNFRSF7: CD27 antigen precursor |
TNFSF8 |
TNFSF8, CD30L, CD30LG: Tumor necrosis factor ligand superfamily member 8 |
0.265 |
Evidence |
|
| TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
CARD4 |
NOD1, CARD4: Nucleotide-binding oligomerization domain-containing protein 1 |
0.265 |
Evidence |
|
| HLA-DOA |
HLA-DOA, HLA-DNA, HLA-DZA: HLA class II histocompatibility antigen, DO alpha cha |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
0.265 |
Evidence |
O
|
| CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.265 |
Evidence |
|
- 
-